SummaryAutomated microanalytic chromogenic coagulation assays allow serial monitoring of critically ill newborn infants. In this study 84 premature infants 126 healthy prematures and 58 neonates with idiopathic respiratory distress syndrome (IRDS)] were studied daily during the first week of life, to investigate the possible significance of hemostatic abnormalities in IRDS.In neonates with IRDS, coagulation factors I1 and X, antithrombin I11 (AT-111), plasminogen, and a2-antiplasmin were significantly lower than control values. Recovery of the initially low AT-111 levels was delayed relative to the other coagulation parameters measured. An AT-I11 r 0.15 U/ml was present within the first 6 h of life in eight patients who developed IRDS, seven of whom died within 48 h. Autopsy of these neonates showed widespread fibrin deposition and hemorrhage in vital organs consistent with intravascular coagulation. These findings indicate that very low levels of AT-I11 are associated with disseminated intravascular coagulation in neonates with IRDS and suggest that a deficiency of AT-I11 is predictive of a poor outcome.
AbbreviationsAT-111, antithrombin 111 DIC, disseminated intravascular coagulation IRDS, idiopathic respiratory distress syndrome IVH, intraventricular hemorrhage DIC is frequently encountered in premature newborn infants suffering from IRDS. Deficiencies in clotting factors and fibrinogen, increased levels of fibrinogenlfibrin degradation products and thrombocytopenia (2,4,19,22,23) have been reported to be caused by DIC. These coagulation abnormalities are associated with clinical symptoms of bleeding (7,8,16,25,29) particularly IVH and fibrin thrombi at autopsy (3,7, 16,3 1) suggesting that DIC contributes to the fatal outcome of this disease. Decreased levels of AT-I11 have been described in early stages of DIC in adult patients (6,26). In cord blood samples of premature infants who developed IRDS, reduced AT-I11 levels have been reported (1 8, 2 1, 34); however, the relationship between AT-I11 activity and the clinical course of IRDS has not yet been thoroughly investigated. The availability of automated chromogenic coagulation assays enables the serial study of several coagulation parameters, and of AT-I11 in particular, in premature neonates with IRDS. These results are correlated with clinical signs and autopsy findings.